FFCP PHASE1:Hg19::chr21:43982002..43982026,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C121 | |||
|description=CAGE_peak_at_chr21:43982002..43982026,+ | |||
|id=chr21:43982002..43982026,+ | |||
|ontology_enrichment_celltype=CL:0002127!8.62e-12!1;CL:0000914!8.62e-12!1;CL:0000911!8.62e-12!1;CL:0000814!8.62e-12!1;CL:0002042!8.62e-12!1;CL:0002039!8.62e-12!1;CL:0002040!8.62e-12!1;CL:0002041!8.62e-12!1;CL:0000946!3.28e-11!1;CL:0000786!3.28e-11!1;CL:0000980!3.28e-11!1 | |||
|ontology_enrichment_celltype_v019=CL:0002127;9.37e-99;1!CL:0000911;9.37e-99;1!CL:0000814;9.37e-99;1!CL:0000791;7.18e-07;18!CL:0000789;7.18e-07;18!CL:0002419;7.18e-07;18 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,9.37e-99,1;CL:0000914,9.37e-99,1;CL:0000911,9.37e-99,1;CL:0000814,9.37e-99,1;CL:0002042,9.37e-99,1;CL:0002039,9.37e-99,1;CL:0002040,9.37e-99,1;CL:0002041,9.37e-99,1;CL:0000893,2.74e-50,2;CL:0002489,2.74e-50,2;CL:0000809,2.74e-50,2;CL:0000808,2.74e-50,2;CL:0000894,2.74e-50,2;CL:0000806,2.74e-50,2;CL:0000807,2.74e-50,2;CL:0000805,2.74e-50,2;CL:0002425,2.74e-50,2;CL:0000791,7.18e-07,18;CL:0000789,7.18e-07,18;CL:0002420,7.18e-07,18;CL:0002419,7.18e-07,18;CL:0000790,7.18e-07,18 | |||
|ontology_enrichment_development_v019=CL:0002425;2.74e-50;2!CL:0000790;7.18e-07;18 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019=DOID:1036;1.07e-13;8!DOID:1240;8.24e-08;39!DOID:2531;1.46e-07;51!DOID:0060083;1.46e-07;51 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.07e-13,8;DOID:1240,2.03e-11,39;DOID:2531,4.95e-09,51;DOID:0060083,4.95e-09,51 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,5.56e-26,4;UBERON:0005058,5.56e-26,4;UBERON:0009113,5.56e-26,4;UBERON:0003295,5.56e-26,4;UBERON:0005562,5.56e-26,4;UBERON:0003351,7.67e-18,6;UBERON:0004177,1.65e-15,7;UBERON:0005057,1.65e-15,7;UBERON:0000974,2.73e-11,10;UBERON:0003408,2.73e-11,10;UBERON:0001042,2.73e-11,10;UBERON:0009145,2.73e-11,10;UBERON:0006562,2.16e-10,11;UBERON:0009722,2.16e-10,11;UBERON:0007690,2.16e-10,11;UBERON:0008814,7.18e-07,18 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0.263766978228454,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.217188844705117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10366105501537,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.109750285408626,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,20.9599219267896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0915694648183434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284567373393656,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.123084805461069,0,0,0,0,0.0986434056369336,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0769502585037971,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.476809736941136,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17472666824203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.171594997861965,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.63460442968852,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121792598380896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206686796501184,0,0,0,0,0,0,0,0,0,0.227662191351298,0,0.115233987555779,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23806443146374,0,0,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr21:43982002..43982026,+ | |||
}} |
Revision as of 13:59, 21 January 2014
Short description: | p@chr21:43982002..43982026, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr21:43982002..43982026, + |
Coexpression cluster: | C121_NK_Natural_CD8_CD4_anaplastic_chronic_B |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 9.37e-99 | 1 |
immature NK T cell | 9.37e-99 | 1 |
effector T cell | 9.37e-99 | 1 |
mature NK T cell | 9.37e-99 | 1 |
immature NK T cell stage IV | 9.37e-99 | 1 |
immature NK T cell stage I | 9.37e-99 | 1 |
immature NK T cell stage II | 9.37e-99 | 1 |
immature NK T cell stage III | 9.37e-99 | 1 |
thymocyte | 2.74e-50 | 2 |
double negative thymocyte | 2.74e-50 | 2 |
double-positive, alpha-beta thymocyte | 2.74e-50 | 2 |
DN4 thymocyte | 2.74e-50 | 2 |
DN1 thymic pro-T cell | 2.74e-50 | 2 |
DN2 thymocyte | 2.74e-50 | 2 |
DN3 thymocyte | 2.74e-50 | 2 |
immature single positive thymocyte | 2.74e-50 | 2 |
early T lineage precursor | 2.74e-50 | 2 |
mature alpha-beta T cell | 7.18e-07 | 18 |
alpha-beta T cell | 7.18e-07 | 18 |
immature T cell | 7.18e-07 | 18 |
mature T cell | 7.18e-07 | 18 |
immature alpha-beta T cell | 7.18e-07 | 18 |
Ontology term | p-value | n |
---|---|---|
thymus | 5.56e-26 | 4 |
hemolymphoid system gland | 5.56e-26 | 4 |
thymic region | 5.56e-26 | 4 |
pharyngeal gland | 5.56e-26 | 4 |
thymus primordium | 5.56e-26 | 4 |
pharyngeal epithelium | 7.67e-18 | 6 |
hemopoietic organ | 1.65e-15 | 7 |
immune organ | 1.65e-15 | 7 |
neck | 2.73e-11 | 10 |
gland of gut | 2.73e-11 | 10 |
chordate pharynx | 2.73e-11 | 10 |
pharyngeal region of foregut | 2.73e-11 | 10 |
pharynx | 2.16e-10 | 11 |
entire pharyngeal arch endoderm | 2.16e-10 | 11 |
early pharyngeal endoderm | 2.16e-10 | 11 |
pharyngeal arch system | 7.18e-07 | 18 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.07e-13 | 8 |
leukemia | 2.03e-11 | 39 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |